Filing Details
- Accession Number:
- 0000899243-21-014635
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-02 18:03:43
- Reporting Period:
- 2021-04-01
- Accepted Time:
- 2021-04-02 18:03:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1655472 | Cindy Tahl | C/O Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-01 | 28,149 | $2.90 | 136,197 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-04-01 | 1,851 | $7.87 | 138,048 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-04-01 | 1,000 | $80.49 | 137,048 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 8,220 | $81.48 | 128,828 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 4,556 | $82.69 | 124,272 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 3,490 | $83.40 | 120,782 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 2,200 | $84.48 | 118,582 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 4,835 | $85.98 | 113,747 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 5,299 | $86.76 | 108,448 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-04-01 | 400 | $87.45 | 108,048 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-04-01 | 28,149 | $0.00 | 28,149 | $2.90 |
Common Stock | Stock Option Right to Buy | Disposition | 2021-04-01 | 1,851 | $0.00 | 1,851 | $7.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-01-07 | No | 4 | M | Direct | |
10,458 | 2023-08-12 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
- Represents the weighted average sale price of the shares sold ranging from $80.02 to $81.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 9.
- Represents the weighted average sale price of the shares sold ranging from $81.02 to $81.85 per share.
- Represents the weighted average sale price of the shares sold ranging from $82.08 to $83.07 per share.
- Represents the weighted average sale price of the shares sold ranging from $83.08 to $84.06 per share.
- Represents the weighted average sale price of the shares sold ranging from $84.08 to $84.97 per share.
- Represents the weighted average sale price of the shares sold ranging from $85.34 to $86.33 per share.
- Represents the weighted average sale price of the shares sold ranging from $86.34 to $87.32 per share.
- Represents the weighted average sale price of the shares sold ranging from $87.36 to $87.53 per share.
- The shares subject to this option vested in 48 equal monthly installments beginning on February 8, 2016.
- 1/2 of the shares subject to this option vested in 48 equal monthly installments beginning on November 4, 2013. The remaining 1/2 of the shares are divided into five equal parts, and 1/5 of such remaining shares vested in 24 equal monthly installments following the Issuer's achievement of one of the five specified performance based milestones.